# Secondary Cancers in Myeloproliferative Neoplasms (MPN-K Study)

> **NCT03745378** · — · COMPLETED · sponsor: **FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS** · enrollment: 1881 (actual)

## Conditions studied

- Polycythemia Vera
- Essential Thrombocythemia
- Myelofibrosis

## Interventions

- **OTHER:** JAK2V617F mutation

## Key facts

- **NCT ID:** NCT03745378
- **Lead sponsor:** FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-15
- **Primary completion:** 2018-07-07
- **Final completion:** 2018-09-30
- **Target enrollment:** 1881 (ACTUAL)
- **Last updated:** 2019-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03745378

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03745378, "Secondary Cancers in Myeloproliferative Neoplasms (MPN-K Study)". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT03745378. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*